Elisa Baldin

Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis

Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study

Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy

Azathioprine for people with multiple sclerosis

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the<scp>MNGIE</scp>International Network

Exposure to breastfeeding and risk of developing multiple sclerosis

Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study

The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power

Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System

Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis

Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres

Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure

Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study